ORAMAB Trademark

Trademark Overview

On Tuesday, June 20, 2017, a trademark application was filed for ORAMAB with the United States Patent and Trademark Office. The USPTO has given the ORAMAB trademark a serial number of 79216395. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 6, 2024. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. The ORAMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for treating inflammatory diseases of the digestive tract
oramab

General Information

Serial Number79216395
Word MarkORAMAB
Filing DateTuesday, June 20, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 6, 2024
Registration Number5472201
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for treating inflammatory diseases of the digestive tract

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Thursday, September 14, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 20, 2017NON-FINAL ACTION WRITTEN
Monday, September 18, 2017ASSIGNED TO EXAMINER
Tuesday, September 19, 2017APPLICATION FILING RECEIPT MAILED
Tuesday, September 26, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 14, 2017REFUSAL PROCESSED BY IB
Wednesday, January 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, September 21, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 26, 2017REFUSAL PROCESSED BY MPU
Friday, January 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 6, 2018GENERIC MADRID TRANSACTION CREATED
Saturday, April 3, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, April 15, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, December 6, 2024CANCELLED SECTION 71
Wednesday, August 6, 2025TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, September 6, 2018GENERIC MADRID TRANSACTION SENT TO IB
Saturday, September 29, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 5, 2021NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

oramab digestive tract diseases inflammatory products treating pharmaceutical